Abstract
A phase I trial of docetaxel was performed to determine the maximum-tolerated dose (MTD), the dose-limiting toxicities, and the incidence and severity of other toxicities in children with refractory solid tumors. Forty-four children received 103 courses of docetaxel administered as a 1-hour intravenous infusion every 21 days. Doses ranged from 55 to 150 mg/m2, MTD was defined in heavily pretreated and less heavily pretreated (< or = 2 prior chemotherapy regimens, no prior bone marrow transplantation [BMT], and no radiation to the spine, skull, ribs, or pelvic bones) patients. Dose-related neutropenia was the primary dose-limiting toxicity. The MTD in the heavily pretreated patient group was 65 mg/m2, but the less heavily pretreated patients tolerated a significantly higher dose of docetaxel (maximum-tolerated dose, 125 mg/m2). Neutropenia and constitutional symptoms consisting of malaise, myalgias, and anorexia were the dose-limiting toxicities at 150 mg/m2 in the less heavily pretreated patients. Thrombocytopenia was not prominent, even in patients who experienced dose-limiting neutropenia. Common nonhematologic toxicities of docetaxel included skin rashes, mucositis, and mild elevations of serum transaminases. Neuropathy was ...Continue Reading
Citations
Jan 31, 1998·Medizinische Klinik·A KretzschmarB Dörken
Apr 28, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E J EstlinM Bernstein
Oct 10, 2006·Future Oncology·Abha A Gupta, Alberto S Pappo
Jul 4, 2013·Cancer Chemotherapy and Pharmacology·D SémiondP Vrignaud
Aug 21, 2014·Neuro-oncology·Emily GirardJames Olson
Oct 22, 2015·Cancer Chemotherapy and Pharmacology·Elizabeth FoxFrank M Balis
Jul 13, 2002·Cancer·Douglas S HawkinsJanet F Eary
Jan 5, 2002·Paediatric Drugs·M PaulussenH Jürgens
Jul 1, 2008·The Oncologist·Aerang KimBrigitte C Widemann
Jul 30, 2015·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Gisela G SlaatsRachel H Giles
Mar 15, 2006·Cancer·Ted ZwerdlingUNKNOWN Children's Oncology Group
Nov 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Debra P LeePeter C Adamson
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brigitte C WidemannElizabeth Fox
Aug 3, 2007·Pediatric Blood & Cancer·Janet L FranklinUNKNOWN Children's Oncology Group
May 20, 2008·Cancer·Fariba NavidNajat C Daw
Jul 9, 2003·Journal of Pediatric Hematology/oncology·Anne-Marie LangevinUNKNOWN Pediatric Oncology Group Study
Jun 23, 2015·British Journal of Clinical Pharmacology·Hoai-Thu ThaiChristine Veyrat-Follet
Jun 24, 2009·Current Treatment Options in Oncology·Wesley HsuJean-Paul Wolinsky
Sep 4, 2009·Journal of Pediatric Hematology/oncology·Jaume MoraCarmen de Torres
Jun 1, 2012·Pediatric Blood & Cancer·Angela D Trobaugh-Lotrario, James H Feusner
Apr 4, 2012·Journal of Pediatric Hematology/oncology·Sally L GeorgePenelope Brock
May 11, 2016·Journal of Pediatric Hematology/oncology·Jonathan C YehKenneth J Cohen
Sep 23, 2016·Pediatric Blood & Cancer·Kathleen DorrisMaryam Fouladi
Dec 17, 2015·Cancer Chemotherapy and Pharmacology·Michela CasanovaAli Varan
Sep 25, 2001·Medical and Pediatric Oncology·L LiuD I Rosenthal
Sep 28, 2013·Journal of Cancer Research and Clinical Oncology·Thomas H Dawson
Mar 23, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa M BarkerDouglas S Hawkins
Aug 18, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth FoxFrank M Balis
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shana JacobsBrigitte C Widemann
Nov 4, 2017·Cancer Research·Christopher C MillsValerie B Sampson
Oct 6, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer K PetersonPeter J Houghton
Jun 20, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Loredana AmorosoGilles Vassal